A detailed history of Nuveen Asset Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 520,434 shares of OGN stock, worth $9.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
520,434
Previous 575,206 9.52%
Holding current value
$9.98 Million
Previous $10.8 Million 0.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$17.45 - $21.96 $955,771 - $1.2 Million
-54,772 Reduced 9.52%
520,434 $10.8 Million
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $1.02 Million - $1.39 Million
74,078 Added 14.78%
575,206 $10.8 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $926,917 - $1.47 Million
-84,650 Reduced 14.45%
501,128 $7.23 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $584,963 - $838,130
-35,260 Reduced 5.68%
585,778 $10.2 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $1.13 Million - $1.45 Million
-58,853 Reduced 8.66%
621,038 $12.9 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $36,242 - $54,279
1,692 Added 0.25%
679,891 $16 Million
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $671,188 - $823,796
-28,794 Reduced 4.07%
678,199 $18.9 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $376,201 - $550,637
16,077 Added 2.33%
706,993 $16.5 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $125,468 - $154,160
-3,963 Reduced 0.57%
690,916 $23.3 Million
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $486,195 - $628,461
-15,967 Reduced 2.25%
694,879 $24.2 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $1.5 Million - $1.94 Million
-52,375 Reduced 6.86%
710,846 $21.6 Million
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $3.95 Million - $4.91 Million
137,843 Added 22.04%
763,221 $25 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $17.8 Million - $23.8 Million
625,378 New
625,378 $18.9 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.